Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

NCT00612677 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped slow accrual - the 1 patient accrued did not go on treatment

Conditions

Lung Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Pemetrexed

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]